Boryung
003850
Company Profile
Business description
Boryung is part of the healthcare sector. The company's business involves the manufacture and marketing of pharmaceutical products. It manufactures a suite of drugs to address various areas such as blood circulation, gastrointestinal, and hypertension. Boryung markets its products globally through over 100 partners.
Contact
136, Changgyeonggung-ro
Boryeong Building
Jongno-gu
Seoul110-750
KORT: +82 807088088
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,651
Stocks News & Analysis
stocks
Will undervalued ASX share show progress in results?
Investors will get to see if the new strategy and capital management framework are working.
stocks
10 best US dividend aristocrats to buy now for 2026
These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.
stocks
What to expect from the January Fed meeting
Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,250.60 | 50.70 | -0.55% |
| CAC 40 | 8,086.39 | 66.43 | -0.81% |
| DAX 40 | 24,847.62 | 46.82 | -0.19% |
| Dow JONES (US) | 49,015.51 | 12.10 | 0.02% |
| FTSE 100 | 10,170.61 | 37.19 | -0.36% |
| HKSE | 27,826.91 | 699.96 | 2.58% |
| NASDAQ | 23,836.30 | 19.20 | 0.08% |
| Nikkei 225 | 53,358.71 | 25.17 | 0.05% |
| NZX 50 Index | 13,412.87 | 98.01 | -0.73% |
| S&P 500 | 6,978.50 | 0.10 | -0.00% |
| S&P/ASX 200 | 8,933.90 | 40.40 | -0.45% |
| SSE Composite Index | 4,151.24 | 11.33 | 0.27% |